Genetic testing provides insights to sudden unexplained deaths in Amish community

January 08, 2020

Rochester, Minn. - Researchers used post-mortem genetic testing to find the underlying cause of multiple sudden deaths in young people and sudden cardiac arrests in two large Amish families.

Using an exome molecular autopsy, Michael Ackerman, M.D., Ph.D., and his associates conducted genetic testing of four siblings who each died suddenly during exercise. Dr. Ackerman is a genetic cardiologist and director of the Windland Smith Rice Comprehensive Sudden Cardiac Death Program at Mayo Clinic. The findings are published in JAMA Cardiology. Dr. Ackerman is the senior author.

Based on a family history of exercise-associated sudden deaths in the young and sudden cardiac arrests, researchers suspected a recessive inheritance pattern because the parents of affected children did not show visible characteristics, or phenotype. This recessive condition requires the inheritance of the genetic variant from each parent, such that the children who are affected have two copies of the variant. If both parents carry a single copy of the genetic variant, their children have a 25% chance of inheriting two copies of the variant and are likely to express the phenotype that puts them at risk for sudden cardiac arrest or sudden death.

"Alarmingly, people with this condition often have an unremarkable clinical course and routine cardiology clinical testing, such as an electrocardiogram or even stress testing, that do not reveal an individual at risk for a sudden cardiac event," Dr. Ackerman says.

A molecular autopsy revealed a common genetic factor among all four siblings. Each had the same homozygous multiexon duplication in RYR2, as did multiple distantly related relatives who also experienced a sudden cardiac arrest during exercise. Researchers then compared a second, unrelated Amish family that also has multiple exertion-related sudden deaths and sudden cardiac arrests in the young. Genetic testing confirmed that both families possessed the exact same gene duplication. To date, 23 family members have been identified as being affected. Of those 23 family members, 18 have tragically died suddenly at a young age.

Identifying which people in these Amish communities are at risk is important for their future, but it is difficult without genetic testing.

"Now that our genetic sleuthing has revealed the underlying genetic cause for these families' tragic events, a simple genetic test can be performed to identify family members at risk for their own sudden cardiac arrest," Dr. Ackerman says. "In fact, identification of unaffected heterozygous carriers may provide potentially lifesaving premarital counseling and reproductive planning for the Amish community."

The researchers are re-engineering blood samples into beating heart cells from two affected people to create a "disease-in-the-dish" cellular model. This effort will provide further insights into the molecular and cellular mechanisms that are causing these tragedies, according to David Tester, first author of the study and lead scientist for the Windland Smith Rice Sudden Death Genomics Laboratory at Mayo Clinic.
Other researchers involved in this study are:

Beth Pitel; Erik Thorland, Ph.D.; John Giudicessi, M.D., Ph.D.; Samantha Hamrick; John Kim, Ph.D.; and Carla Haglund-Turnquist -- all of Mayo Clinic

Hannah Bombei; Dianne Atkins, M.D.; Luis Ochoa Nunez, M.D.; and Ian Law, M.D. -- all from The University of Iowa

Kristi Fitzgerald and Joe Temple, M.D. -- both from Nemours/Alfred I. duPont Hospital for Children

Barbara Russell and Christopher Johnsrude, M.D. -- both from University of Louisville

The study was supported by the Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program.

About Mayo Clinic

Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news and An Inside Look at Mayo Clinic for more information about Mayo.

Media contact:

Terri Malloy, Mayo Clinic Public Affairs, 507-284-5005,

Mayo Clinic

Related Genetic Testing Articles from Brightsurf:

Genetic testing cost effective for newly diagnosed GIST
UC San Diego School of Medicine researchers reported that genetic testing is cost-effective and beneficial for newly diagnosed patients with metastatic gastrointestinal stromal tumors (GIST), a rare type of cancer.

Genetic testing could improve screening for osteoporosis
An international team of scientists has developed a novel genetic measure that could dramatically improve how doctors assess the risk of sustaining a fracture due to osteoporosis or fragility

New recommendations on genetic testing for prostate cancer
Genetic testing for prostate cancer is still not common. New guidelines show why it's important, and which genes to test for.

For acute myeloid leukemia, genetic testing is often worth the wait
New tailored therapies offer exciting prospects for treating acute myeloid leukemia (AML), but taking advantage of them may require waiting a week or more for genetic testing before starting treatment, posing a dilemma for doctors and patients facing this deadly and often fast-moving disease.

Genetic testing among individuals with ASD
Professional medical societies recommend certain genetic tests for individuals with autism spectrum disorder (ASD).

Breast cancer patients to be evaluated for genetic testing
The guidance from the ACMG differs from a consensus guideline issued in February by the American Society of Breast Surgeons, which recommended genetic testing for all newly diagnosed patients with breast cancer.

New technique isolates placental cells for non-invasive genetic testing
A new technique for isolating cells carrying the full fetal genome from cervical swabs could enable doctors to diagnose genetic disorders without using needles to harvest cells from the placenta.

BRCA1/2 genetic testing recommendations still leave issues unresolved
The U.S. Preventive Services Task Force offers new guidelines on BRCA1/2 genetic testing.

Does genetic testing pose psychosocial risks?
For the last quarter century, researchers have been asking whether genetic information might have negative psychosocial effects.

Genetic testing has a data problem; New software can help
As at-home genetic testing becomes more popular, companies are grappling with how to store all the accumulating data and how to process results quickly.

Read More: Genetic Testing News and Genetic Testing Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to